메뉴 건너뛰기




Volumn 71, Issue 1, 2016, Pages 156-161

In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; CEFALOTIN; DORIPENEM; ERTAPENEM; IMIPENEM; KPC 2 PROTEIN; MEROPENEM; NDM 1 PROTEIN; OXA 48 PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

EID: 84960096359     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv294     Document Type: Article
Times cited : (64)

References (26)
  • 1
    • 84860516573 scopus 로고    scopus 로고
    • Carbapenem resistance in Enterobacteriaceae: here is the storm!
    • Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012; 18: 263-72.
    • (2012) Trends Mol Med , vol.18 , pp. 263-272
    • Nordmann, P.1    Dortet, L.2    Poirel, L.3
  • 2
    • 84867166640 scopus 로고    scopus 로고
    • Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions
    • Tzouvelekis LS, Markogiannakis A, Psichogiou M et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012; 25: 682-707.
    • (2012) Clin Microbiol Rev , vol.25 , pp. 682-707
    • Tzouvelekis, L.S.1    Markogiannakis, A.2    Psichogiou, M.3
  • 3
    • 84930486688 scopus 로고    scopus 로고
    • Global spread of carbapenemaseproducing Enterobacteriaceae
    • Nordmann P, Naas T, Poirel L. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-8.
    • (2011) Emerg Infect Dis , vol.17 , pp. 1791-1798
    • Nordmann, P.1    Naas, T.2    Poirel, L.3
  • 4
    • 84882712084 scopus 로고    scopus 로고
    • Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
    • Munoz-Price LS, Poirel L, Bonomo RA et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13: 785-96.
    • (2013) Lancet Infect Dis , vol.13 , pp. 785-796
    • Munoz-Price, L.S.1    Poirel, L.2    Bonomo, R.A.3
  • 5
    • 84859913969 scopus 로고    scopus 로고
    • Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
    • Cantón R, Akóva M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-31.
    • (2012) Clin Microbiol Infect , vol.18 , pp. 413-431
    • Cantón, R.1    Akóva, M.2    Carmeli, Y.3
  • 8
    • 84896940320 scopus 로고    scopus 로고
    • Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems
    • Daikos GL, Tsaousi S, Tzouvelekis LS et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58: 2322-8.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 2322-2328
    • Daikos, G.L.1    Tsaousi, S.2    Tzouvelekis, L.S.3
  • 9
    • 84908528845 scopus 로고    scopus 로고
    • Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
    • pii=20939
    • Monaco M, Giani T, Raffone M et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19: pii=20939.
    • (2014) Euro Surveill , vol.19
    • Monaco, M.1    Giani, T.2    Raffone, M.3
  • 10
    • 84877700761 scopus 로고    scopus 로고
    • Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae
    • Wiskirchen DE, Crandon JL, Nicolau DP. Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae. Int J Antimicrob Agents 2013; 41: 582-5.
    • (2013) Int J Antimicrob Agents , vol.41 , pp. 582-585
    • Wiskirchen, D.E.1    Crandon, J.L.2    Nicolau, D.P.3
  • 11
    • 84880317088 scopus 로고    scopus 로고
    • Efficacy of humanized carbapenem exposures against New Delhi metallo-b-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model
    • Wiskirchen DE, Nordmann P, Crandon JL et al. Efficacy of humanized carbapenem exposures against New Delhi metallo-b-lactamase (NDM-1)-producing Enterobacteriaceae in a murine infection model. Antimicrob Agents Chemother 2013; 57: 3936-40.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 3936-3940
    • Wiskirchen, D.E.1    Nordmann, P.2    Crandon, J.L.3
  • 12
    • 78049319835 scopus 로고    scopus 로고
    • Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases
    • Mammeri H, Guillon H, Eb F et al. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases. Antimicrob Agents Chemother 2010; 54: 4556-60.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 4556-4560
    • Mammeri, H.1    Guillon, H.2    Eb, F.3
  • 13
    • 84926465439 scopus 로고    scopus 로고
    • Heterogeneous hydrolytic features for OXA-48-like β-lactamases
    • Oueslati S, Nordmann P, Poirel L. Heterogeneous hydrolytic features for OXA-48-like β-lactamases. J Antimicrob Chemother 2015; 70: 1059-63.
    • (2015) J Antimicrob Chemother , vol.70 , pp. 1059-1063
    • Oueslati, S.1    Nordmann, P.2    Poirel, L.3
  • 14
    • 84924068166 scopus 로고    scopus 로고
    • Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24
    • CLSI, Wayne, PA, USA
    • Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
    • (2014)
  • 15
    • 80052883915 scopus 로고    scopus 로고
    • In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
    • BerÇot B, Poirel L, Dortet L et al. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae. J Antimicrob Chemother 2011; 66: 2295-7.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 2295-2297
    • BerÇot, B.1    Poirel, L.2    Dortet, L.3
  • 16
    • 77957795090 scopus 로고    scopus 로고
    • In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae
    • Elemam A, Rahimian J, Doymaz M. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. J Clin Microbiol 2010; 48: 3558-62.
    • (2010) J Clin Microbiol , vol.48 , pp. 3558-3562
    • Elemam, A.1    Rahimian, J.2    Doymaz, M.3
  • 17
    • 0038601510 scopus 로고    scopus 로고
    • Synergy, antagonism, and what the chequerboard puts between them
    • Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 1
    • Odds, F.C.1
  • 18
    • 80051805279 scopus 로고    scopus 로고
    • Methods for determining bactericidal activity and antimicrobial interactions: synergy testing, time-kill curves, and population analysis
    • In: Schwalbe R, Steele-Moore L, Goodwin AC, eds. Boca Raton, FL: CRC Press
    • Verma P. Methods for determining bactericidal activity and antimicrobial interactions: synergy testing, time-kill curves, and population analysis. In: Schwalbe R, Steele-Moore L, Goodwin AC, eds. Antimicrobial Susceptibility Testing Protocols. Boca Raton, FL: CRC Press, 2007; 275-98.
    • (2007) Antimicrobial Susceptibility Testing Protocols , pp. 275-298
    • Verma, P.1
  • 19
    • 0018631560 scopus 로고
    • Comparison of techniques for measurement of in vitro antibiotic synergism
    • Norden CW, Wentzel H, Keleti E. Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis 1979; 140: 629-33.
    • (1979) J Infect Dis , vol.140 , pp. 629-633
    • Norden, C.W.1    Wentzel, H.2    Keleti, E.3
  • 20
    • 84876267557 scopus 로고    scopus 로고
    • Effectiveness of a doublecarbapenem regimen for infections in humans due to carbapenemaseproducing pandrug-resistant Klebsiella pneumoniae
    • Giamarellou H, Galani L, Baziaka F et al. Effectiveness of a doublecarbapenem regimen for infections in humans due to carbapenemaseproducing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 2388-90.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 2388-2390
    • Giamarellou, H.1    Galani, L.2    Baziaka, F.3
  • 21
    • 84877847319 scopus 로고    scopus 로고
    • Successful ertapenemdoripenem combination treatment of bacteremic ventilatorassociated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae
    • Ceccarelli G, Falcone M, Giordano A et al. Successful ertapenemdoripenem combination treatment of bacteremic ventilatorassociated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 2900-1.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 2900-2901
    • Ceccarelli, G.1    Falcone, M.2    Giordano, A.3
  • 22
    • 79956313039 scopus 로고    scopus 로고
    • Double-carbapenem therapy for carbapenemaseproducing Klebsiella pneumoniae
    • Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemaseproducing Klebsiella pneumoniae. Antimicrob Agents Chemother 2011; 55: 3002-4.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3002-3004
    • Bulik, C.C.1    Nicolau, D.P.2
  • 23
    • 84903901479 scopus 로고    scopus 로고
    • Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
    • Oliva A, D'Abramo A, D'Agostino C et al. Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections. J Antimicrob Chemother 2014; 69: 1718-20.
    • (2014) J Antimicrob Chemother , vol.69 , pp. 1718-1720
    • Oliva, A.1    D'Abramo, A.2    D'Agostino, C.3
  • 24
    • 84862840426 scopus 로고    scopus 로고
    • Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrugresistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
    • Samonis G, Maraki S, Karageorgopoulos DE et al. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrugresistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 2012; 31: 695-701.
    • (2012) Eur J Clin Microbiol Infect Dis , vol.31 , pp. 695-701
    • Samonis, G.1    Maraki, S.2    Karageorgopoulos, D.E.3
  • 25
    • 84872871981 scopus 로고    scopus 로고
    • Metallo-b-lactamase structure and function
    • Palzkill T. Metallo-b-lactamase structure and function. Ann N YAcad Sci 2013; 1277: 91-104.
    • (2013) Ann N YAcad Sci , vol.1277 , pp. 91-104
    • Palzkill, T.1
  • 26
    • 84862585028 scopus 로고    scopus 로고
    • Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae
    • Thomson KS. Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 4037.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 4037
    • Thomson, K.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.